Subscribe
shutterstock_1169047330_markvanscyoc-1
markvanscyoc / shutterstock.com
7 May 2020Americas

USPTO temporarily allows online plant patent filings

The US Patent and Trademark Office (USPTO) will allow plant patent applications to be filed online due to the COVID-19 pandemic, it has announced.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Patent filing strategies for pharma startups
16 March 2021   Patents are a key asset for pharmaceutical startups, but where are they choosing to file? Jian Siang Poh and Angus Fairbairn of Marks & Clerk report.
Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.
Africa
Plant breeders facing ‘critical situation’ ask nations for support
9 April 2020   The International Community of Breeders of Asexually Reproduced Ornamental and Fruit Varieties has implored countries to implement support measures for breeders amid the pandemic.


Editor's picks

Trouble at the USPTO—Part II: Bracing for impact
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025

Editor's picks

Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025
Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025
Americas
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
6 March 2025
Careers
Jones Day adds experienced patent litigators from Weil
4 March 2025
Americas
LSPN finalists revealed for first-ever US awards
3 March 2025
Europe
‘It’s business as usual’: ERS Genomics enjoys new EPO patent after CRISPR gambit pays off
27 February 2025

More on this story

Big Pharma
Patent filing strategies for pharma startups
16 March 2021   Patents are a key asset for pharmaceutical startups, but where are they choosing to file? Jian Siang Poh and Angus Fairbairn of Marks & Clerk report.
Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.
Africa
Plant breeders facing ‘critical situation’ ask nations for support
9 April 2020   The International Community of Breeders of Asexually Reproduced Ornamental and Fruit Varieties has implored countries to implement support measures for breeders amid the pandemic.

More on this story

Big Pharma
Patent filing strategies for pharma startups
16 March 2021   Patents are a key asset for pharmaceutical startups, but where are they choosing to file? Jian Siang Poh and Angus Fairbairn of Marks & Clerk report.
Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.
Africa
Plant breeders facing ‘critical situation’ ask nations for support
9 April 2020   The International Community of Breeders of Asexually Reproduced Ornamental and Fruit Varieties has implored countries to implement support measures for breeders amid the pandemic.

More features

Patent cliff: 5 blockbusters running out of road
Herbert Smith Freehills expands German tech patent team
‘Always new twists’: Bayer legal team on defending a $4bn drug
Novartis and MSN feud intensifies after Fed Circ denies rehearing
EU court signals tough stance on ‘pay-for-delay’ pharma deals
Panitch Schwarze hires experienced ex-USPTO examiner
Fed Circ affirms generic’s litigation costs of $12m are tax-deductible
Genmab fights claim over 'secrets theft' behind $1.8bn takeover